Will SoundHound AI Stock Recover?
SoundHound AI (NASDAQ:SOUN) is a leading maker of artificial intelligence…
Sell
32
FUL Quote, Financials, Valuation and Earnings
Last price:
$54.77
Seasonality move
:
5.03%
Day range:
$54.04 - $57.43
52-week range:
$52.59 - $87.67
Dividend yield:
1.63%
P/E ratio:
27.39x
P/S ratio:
0.87x
P/B ratio:
1.67x
Volume:
825.1K
Avg. volume:
576.3K
1-year change:
-31.31%
Market cap:
$3B
Revenue:
$3.6B
EPS (TTM):
$2.00
Analysts' Opinion
-
Consensus RatingH.B. Fuller has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $63.40, H.B. Fuller has an estimated upside of 15.76% from its current price of $54.77.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $50.00 representing 8.71% downside risk from its current price of $54.77.
Fair Value
-
According to the consensus of 5 analysts, H.B. Fuller has 15.76% upside to fair value with a price target of $63.40 per share.
FUL vs. S&P 500
-
Over the past 5 trading days, H.B. Fuller has overperformed the S&P 500 by 3.83% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
H.B. Fuller does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
H.B. Fuller revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter H.B. Fuller reported revenues of $788.7M.
Earnings Growth
-
H.B. Fuller earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter H.B. Fuller reported earnings per share of $0.24.
Enterprise value:
5B
EV / Invested capital:
1.27x
Price / LTM sales:
0.87x
EV / EBIT:
16.99x
EV / Revenue:
1.42x
PEG ratio (5yr expected):
0.88x
EV / Free cash flow:
68.85x
Price / Operating cash flow:
42.24x
Enterprise value / EBITDA:
10.72x
Gross Profit (TTM):
$1B
Return On Assets:
2.3%
Net Income Margin (TTM):
3.17%
Return On Equity:
6.24%
Return On Invested Capital:
2.95%
Operating Margin:
5.89%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-02-28 | 2024-02-28 | 2025-02-28 | 2024-02-28 | 2025-02-28 | |
| Income Statement | ||||||
| Revenue | $3.7B | -- | $3.5B | -- | $788.7M | |
| Gross Profit | $965.6M | -- | $1B | -- | $227.1M | |
| Operating Income | $352.8M | -- | $343.7M | -- | $46.4M | |
| EBITDA | $490.9M | -- | $470.6M | -- | $93.4M | |
| Diluted EPS | $2.96 | -- | $2.00 | -- | $0.24 | |
| Period Ending | 2021-02-28 | 2022-02-28 | 2023-02-28 | 2024-02-28 | 2025-02-28 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.1B | $1.3B | $1.3B | -- | $1.2B | |
| Total Assets | $4.1B | $4.6B | $4.5B | -- | $5B | |
| Current Liabilities | $568.2M | $721.9M | $643.2M | -- | $614.8M | |
| Total Liabilities | $2.7B | $3B | $2.9B | -- | $3.2B | |
| Total Equity | $1.4B | $1.6B | $1.6B | -- | $1.8B | |
| Total Debt | $1.8B | $1.9B | $1.9B | -- | $2.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-02-28 | 2024-02-28 | 2025-02-28 | 2024-02-28 | 2025-02-28 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $279.7M | -- | $202.2M | -- | -$52.9M | |
| Cash From Investing | -$164.8M | -- | -$485.7M | -- | -$121.4M | |
| Cash From Financing | -$24.3M | -- | $240.4M | -- | $111.4M | |
| Free Cash Flow | $151M | -- | $73.3M | -- | -$85.9M | |
FUL
Sector
Market Cap
$3B
$18.5M
Price % of 52-Week High
62.48%
61.96%
Dividend Yield
1.63%
0%
Shareholder Yield
1.88%
1.21%
1-Year Price Total Return
-31.31%
-10.76%
Beta (5-Year)
1.415
1.011
Dividend yield:
1.63%
Annualized payout:
$0.87
Payout ratio:
43.23%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$54.51
200-day SMA
Sell
Level
$72.67
Bollinger Bands (100)
Sell
Level
57.37 - 73.61
Chaikin Money Flow
Buy
Level
28.8M
20-day SMA
Sell
Level
$54.89
Relative Strength Index (RSI14)
Sell
Level
45.34
ADX Line
Buy
Level
31.78
Williams %R
Neutral
Level
-58.3969
50-day SMA
Sell
Level
$58.61
MACD (12, 26)
Sell
Level
-1.11
25-day Aroon Oscillator
Sell
Level
-48
On Balance Volume
Neutral
Level
50.1M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.4344)
Sell
CA Score
(Annual)
Level (-0.4719)
Buy
Beneish M-Score
(Annual)
Level (-2.7132)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (0.4521)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives and Construction Adhesives. It generates the maximum revenue from hygiene, health and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based and solvent-based products for applications in various markets, including packaging , converting, nonwoven and hygiene (disposable diapers, feminine care and medical garments) and health and beauty. The company generates around half of its revenue in the United States.
Stock Forecast FAQ
In the current month, FUL has received 1 Buy ratings 4 Hold ratings, and 0 Sell ratings. The FUL average analyst price target in the past 3 months is $63.40.
-
Where Will H.B. Fuller Stock Be In 1 Year?
According to analysts, the consensus estimate is that H.B. Fuller share price will rise to $63.40 per share over the next 12 months.
-
What Do Analysts Say About H.B. Fuller?
Analysts are divided on their view about H.B. Fuller share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that H.B. Fuller is a Sell and believe this share price will drop from its current level to $50.00.
-
What Is H.B. Fuller's Price Target?
The price target for H.B. Fuller over the next 1-year time period is forecast to be $63.40 according to 5 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is FUL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for H.B. Fuller is a Hold. 4 of 5 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of FUL?
You can purchase shares of H.B. Fuller via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase H.B. Fuller shares.
-
What Is The H.B. Fuller Share Price Today?
H.B. Fuller was last trading at $54.77 per share. This represents the most recent stock quote for H.B. Fuller. Yesterday, H.B. Fuller closed at $54.77 per share.
-
How To Buy H.B. Fuller Stock Online?
In order to purchase H.B. Fuller stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Stocks Did Warren Buffett Just Buy?
In Q4 of last year, Warren Buffett added to or…
Is it Finally Time to Buy Medical Properties Trust?
Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
78
AJINY alert for Mar 29
Ajinomoto [AJINY] is up 99.61% over the past day.
Buy
85
SLNO alert for Mar 29
Soleno Therapeutics [SLNO] is up 6.8% over the past day.
Buy
69
AGX alert for Mar 29
Argan [AGX] is up 19.83% over the past day.
